Phase
Condition
Scalp Disorders
Hair Loss
Alopecia
Treatment
N/AClinical Study ID
Ages 20-50 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Norwood-Hamilton Type III vertex, IV, or V
Exclusion
Exclusion Criteria:
History or evidence of hair loss other than androgenetic alopecia
Scarring of the scalp
Use of dutasteride in previous 18 months
Use of finasteride within previous 12 months
Hair transplantation or hair weaving within 6 months
Use of Minoxidil within previous 6 months
Use of drugs with anti-androgenetic/androgenetic properties within previous 6 months
Use of Drugs that cause hypertrichosis or hypotrichosis within previous 6 months
Light or laser treatment of scalp within previous 3 months
Cosmetic products aimed at improving or correcting signs of hair loss within previous 2 weeks
Study Design
Study Description
Connect with a study center
GSK Investigational Site
Caba, Buenos Aires C1055AAO
ArgentinaSite Not Available
GSK Investigational Site
Ciudad Autonoma de Buenos Aires, Buenos Aires C1425BEA
ArgentinaSite Not Available
GSK Investigational Site
La Boca, Buenos Aires C1155AHD
ArgentinaSite Not Available
GSK Investigational Site
Buenos Aires, 1425
ArgentinaSite Not Available
GSK Investigational Site
Santiago, Región Metro De Santiago 7580206
ChileSite Not Available
GSK Investigational Site
Viña del Mar, ValparaÃso 252 0000
ChileSite Not Available
GSK Investigational Site
Viña del Mar, Valparaíso 252 0000
ChileSite Not Available
GSK Investigational Site
Fukuoka, 812-0025
JapanSite Not Available
GSK Investigational Site
Osaka, 532-0003
JapanSite Not Available
GSK Investigational Site
Tokyo, 160-0022
JapanSite Not Available
GSK Investigational Site
Naucalpan, Estado De México 11200
MexicoSite Not Available
GSK Investigational Site
Zapopan, Jalisco, Jalisco 45190
MexicoSite Not Available
GSK Investigational Site
Monterrey, Nuevo León 64460
MexicoSite Not Available
GSK Investigational Site
Mazatlan, Sinaloa, Sinaloa 82126
MexicoSite Not Available
GSK Investigational Site
Mexico City, 03720
MexicoSite Not Available
GSK Investigational Site
Mexico city, 06780
MexicoSite Not Available
GSK Investigational Site
Lima 41, Lima Lima 41
PeruSite Not Available
GSK Investigational Site
Lima, Lima 27
PeruSite Not Available
GSK Investigational Site
Lima Cercado, LIMA 01
PeruSite Not Available
GSK Investigational Site
Makati City, 1200
PhilippinesSite Not Available
GSK Investigational Site
Manila, 1000
PhilippinesSite Not Available
GSK Investigational Site
Quezon City,
PhilippinesSite Not Available
GSK Investigational Site
Tanauan City, Batangas, 4232
PhilippinesSite Not Available
GSK Investigational Site
Moscow,, 107076
Russian FederationSite Not Available
GSK Investigational Site
Nizhny Novgorod, 603950
Russian FederationSite Not Available
GSK Investigational Site
Ryazan, 390046
Russian FederationSite Not Available
GSK Investigational Site
St'Petersburg, 192102
Russian FederationSite Not Available
GSK Investigational Site
St-Petersburg, 196084
Russian FederationSite Not Available
GSK Investigational Site
Tainan, 70403
TaiwanSite Not Available
GSK Investigational Site
Taipei,
TaiwanSite Not Available
GSK Investigational Site
Bangkoknoi Bangkok, 10700
ThailandSite Not Available
GSK Investigational Site
Chiang Mai, 50200
ThailandSite Not Available
GSK Investigational Site
Patumwan Bangkok, 10330
ThailandSite Not Available
GSK Investigational Site
Rajthevee Bangkok, 10400
ThailandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.